Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients

Background: Stereotactic ablative body radiotherapy (SABR) is one of the treatment options for oligometastatic renal cell carcinoma (RCC) but is limited by a lack of data to evaluate high-dose SABR to all/multiple sites. Objective: This study retrospectively investigated the efficacy and prognostic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ming-Wei Ma, Hong-Zhen Li, Xian-Shu Gao, Ming-Zhu Liu, Huan Yin, Kai-Wei Yang, Jia-Yan Chen, Xue-Ying Ren, Dian Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-10-01
Col·lecció:	Current Oncology
Matèries:	stereotactic ablative radiation stereotactic body radiation therapy renal cell carcinoma oligometastasis
Accés en línia:	https://www.mdpi.com/1718-7729/29/10/619
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!